Tanja K. Froehlich

Clinical importance of risk variants in the dihydropyrimidine dehydrogenase gene for the prediction of early‐onset fluoropyrimidine toxicity

Tanja K. Froehlich, Ursula Amstutz, Stefan Aebi et al. · International Journal of Cancer · 2014 · 142 citations · Full text

Haplotype Hapb3, Genetics, Genetic Epidemiology +26

Gender-specific elimination of continuous-infusional 5-fluorouracil in patients with gastrointestinal malignancies: results from a prospective population pharmacokinetic study

F Mueller, Barbara Büchel, Dieter Köberle et al. · Cancer Chemotherapy and Pharmacology · 2012 · 94 citations · Full text

Oncology, Gastrointestinal Oncology, Medicine +7

Predicting 5-Fluorouracil Toxicity: DPD Genotype and 5,6-Dihydrouracil: Uracil Ratio

Johanna Sistonen, Barbara Büchel, Tanja K. Froehlich et al. · Pharmacogenomics · 2014 · 60 citations

Accuracy of serological testing for SARS‐CoV‐2 antibodies: First results of a large mixed‐method evaluation study

Daniel Brigger, Michael P. Horn, Luke F. Pennington et al. · Allergy · 2020 · 39 citations · Full text

Rs895819 in <scp><i>MIR27A</i></scp> improves the predictive value of <scp><i>DPYD</i></scp> variants to identify patients at risk of severe fluoropyrimidine‐associated toxicity

Didier Meulendijks, Linda M. Henricks, Ursula Amstutz et al. · International Journal of Cancer · 2016 · 32 citations · Full text

Genetic Epidemiology, Human Polymorphism, Pathology +23